+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Prostate Cancer Diagnostics"

From
Prostate Cancer Diagnostics Market Report 2025 - Product Thumbnail Image

Prostate Cancer Diagnostics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Prostate Cancer Diagnostics Market - Global Forecast 2025-2030 - Product Thumbnail Image

Prostate Cancer Diagnostics Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 193 Pages
  • Global
From
Prostate Cancer Diagnostics - Global Strategic Business Report - Product Thumbnail Image

Prostate Cancer Diagnostics - Global Strategic Business Report

  • Report
  • September 2025
  • 172 Pages
  • Global
From
From
Oncology Diagnostics: Global Markets - Product Thumbnail Image

Oncology Diagnostics: Global Markets

  • Report
  • May 2025
  • 192 Pages
  • Global
From
Mens Health Diagnostics Market - Global Forecast 2025-2030 - Product Thumbnail Image

Mens Health Diagnostics Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 196 Pages
  • Global
From
From
From
Exosome Diagnostics and Therapeutics: Global Markets 2021-2026 - Product Thumbnail Image

Exosome Diagnostics and Therapeutics: Global Markets 2021-2026

  • Report
  • November 2021
  • 255 Pages
  • Global
From
Global Oncology Diagnostics Market 2020-2025 - Product Thumbnail Image

Global Oncology Diagnostics Market 2020-2025

  • Report
  • May 2021
  • 174 Pages
  • Global
From
From
From
From
From
Loading Indicator

The Prostate Cancer Diagnostics market is a segment of the Diagnostics industry that focuses on the detection and diagnosis of prostate cancer. Diagnostic tests for prostate cancer include digital rectal exams, prostate-specific antigen (PSA) tests, and biopsies. These tests are used to detect the presence of cancer, as well as to monitor the progression of the disease. In recent years, advances in technology have enabled the development of more accurate and reliable diagnostic tests for prostate cancer. These tests have improved the accuracy of diagnosis and have enabled earlier detection of the disease. Additionally, the development of new treatments for prostate cancer has increased the demand for diagnostic tests. The Prostate Cancer Diagnostics market is highly competitive, with a number of companies offering a range of diagnostic tests. Some of the major players in the market include Abbott Laboratories, Becton Dickinson, Siemens Healthineers, and Roche Diagnostics. Show Less Read more